Not Tagged
Not Tagged
['sclc', 'nsclc', 'pdl']
#asco22 dr. presents outcomes of 1l io +/- chemo in nsclc by #kras and pdl1 status. do pts with kras+ nsclc respond differently to io +/- chemo relative to kras wt? 1430 pts with known kras status, 39% with mutation. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him